HB 3834
  • Introduced
    Feb 02, 2026
  • Passed House
    Mar 11, 2026
  • Passed Senate
    Apr 29, 2026
  • Became Law
    May 12, 2026
HB 3834
Oklahoma House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.
Last Action See all actions
House • May 12, 2026: Approved by Governor 05/12/2026
Latest Bill Text See all bill texts
Enrolled (final version)

Summary

Comments on HB 3834

Tweets

Whip Lists

Sponsors
Votes
Feb 11, 2026, House
DO PASS
YES: 5
NO: 0
OTHER: 0
YES: 5

NO: 0

    OTHER: 0
    Sources
    Feb 19, 2026, House
    DO PASS
    YES: 10
    NO: 0
    OTHER: 0
    YES: 10

    NO: 0

      OTHER: 0
      Sources
      Mar 11, 2026, House
      THIRD READING
      YES: 68
      NO: 23
      OTHER: 8
      YES: 68

      NO: 23

      EXCUSED: 8

      Sources
      Apr 22, 2026, Senate
      HOUSE BILL 3834 THIRD READING Frix Ibogaine clinical trials; Oklahoma Breakthrough
      YES: 0
      NO: 0
      OTHER: 0
      YES: 0

        NO: 0

        ABSTAIN: 1
        • AMD HB3834 PCS - ADOPTED (Request No: 3978)

        Sources
        Apr 29, 2026, Senate
        HOUSE BILL 3834 THIRD READING Frix Ibogaine clinical trials; Oklahoma Breakthrough
        YES: 0
        NO: 9
        OTHER: 6
        YES: 0

          NO: 9

          NOT VOTING: 33

          EXCUSED: 6

          Sources
          May 06, 2026, House
          FOURTH READING
          YES: 69
          NO: 21
          OTHER: 9
          YES: 69

          NO: 21

          EXCUSED: 9

          Sources
          Actions
          • May 12, 2026 | House
            • Approved by Governor 05/12/2026
          • May 06, 2026 | House
            • Sent to Governor
          • May 06, 2026 | Senate
            • Enrolled measure signed, returned to House
          • May 06, 2026 | House
            • SA's read, adopted
            • Fourth Reading, Measure passed: Ayes: 69 Nays: 21
            • Referred for enrollment
            • Enrolled, signed, to Senate
          • Apr 30, 2026 | House
            • SA's received
          • Apr 30, 2026 | Senate
            • Engrossed to House
          • Apr 29, 2026 | Senate
            • General Order, Considered
            • Measure passed: Ayes: 33 Nays: 9
            • Referred for engrossment
          • Apr 27, 2026 | Senate
            • Placed on General Order
          • Apr 22, 2026 | Senate
            • Reported Do Pass, amended by committee substitute Appropriations committee; CR filed
          • Apr 13, 2026 | Senate
            • Reported Do Pass Health and Human Services committee; CR filed
            • Referred to Appropriations
          • Apr 01, 2026 | Senate
            • Second Reading referred to Health and Human Services Committee then to Appropriations Committee
          • Mar 12, 2026 | Senate
            • First Reading
          • Mar 12, 2026 | House
            • Engrossed, signed, to Senate
          • Mar 11, 2026 | House
            • General Order
            • Amended
            • Third Reading, Measure passed: Ayes: 68 Nays: 23
            • Referred for engrossment
          • Feb 19, 2026 | House
            • CR; Do Pass Health and Human Services Oversight Committee
          • Feb 11, 2026 | House
            • Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health
            • Coauthored by Representative(s) Pae
            • Authored by Senator Frix (principal Senate author)
          • Feb 03, 2026 | House
            • Second Reading referred to Health and Human Services Oversight
            • Referred to Public Health
          • Feb 02, 2026 | House
            • First Reading
            • Authored by Representative May
          Bill Texts
          Documents
          Sources